Search Results 211-220 of 15433 for infliximab

  1. https://www.mayoclinic.org/arabic_patient_consumer_faq.xml

  2. Publications - Gui Piovezani Ramos, M.D. - Mayo Clinic

    Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis. Clin Med Insights Case Rep. 2017; 10:1179547617724776 Epub 2017 Aug 24. View PubMed ...

  3. Health Topics - Mayo Clinic News Network

    The burden of cancer is different for everyone, and life stages can play a role in how it affects people. For adolescents and young adults[...] ...

  4. Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis - Mayo Clinic

    TNF-alpha inhibitors including but not limited to infliximab (Remicade) or adalimumab (Humira) within 12 weeks of Day 0; Any biological agent within 12 weeks ...

  5. I have Medicaid or a managed Medicaid product — Cancer Patients Only - Mayo Clinic

    Because Medicaid requires little to no insurance premium or out of pocket, traditional copay and grant assistance programs are limited. However, it is important ...

  6. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work in ...

  7. A Study to Evaluate Impact of COVID-19 on Inflammatory Bowel Disease - Mayo Clinic

    About this study. The purpose of this study is to understand the impact of the COVID pandemic on IBD patients, including infection rates and complications ...

  8. Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Improving the Quality of Care for Adults with Inflammatory Bowel Disease - Mayo Clinic

    The purpose of this study is to demonstrate the impact of an Adult Inflammatory Bowel Disease (IBD) learning health system approach that enables patients and ...

  10. Rilonacept in Subjects with Cardiac Sarcoidosis - Mayo Clinic

    TNF inhibitors within 2-8 weeks of or 5 half-lives (etanercept within 2 weeks; infliximab, certolizumab, golimumab, or adalimumab within 8 weeks) prior to ...